Roberto Gedaly
Overview
Explore the profile of Roberto Gedaly including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
107
Citations
1255
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bharadwaj R, Orozco G, Mei X, El-Haddad H, Gedaly R, Gupta M
Am J Transplant
. 2024 Nov;
PMID: 39615631
There is limited information on access and outcomes of patients living with human immunodeficiency virus (HIV) (PLWH) who have undergone pancreas transplantation. We conducted a retrospective cohort study analyzing data...
2.
Gedaly R, Orozco G, Lewis L, Valvi D, Chapelin F, Khurana A, et al.
Am J Transplant
. 2024 Nov;
PMID: 39515758
The manufacturing process of regulatory T (Treg) cells for clinical application begins with the positive selection of CD25 cells using superparamagnetic iron oxide nanoparticle (SPION)-conjugated anti-CD25 antibodies (spCD25) and immunomagnetic...
3.
Salama F, Thakral N, Leyson C, Konjeti V, Benrajab K, Hawk G, et al.
Int J Hepatol
. 2024 Nov;
2024:3879328.
PMID: 39484627
: Focal liver lesions (FLL) are one of the most common indications for hepatology and hepatobiliary surgery consultation. In this retrospective study, we aim to assess if contrast-enhanced ultrasound (CEUS)...
4.
Orozco G, Cannon R, Mei X, Inabnet 3rd W, Evers B, Gedaly R, et al.
Surgery
. 2024 Sep;
176(6):1754-1760.
PMID: 39299857
Background: Orthotopic liver transplantation is the recommended treatment option for patients with early-stage hepatocellular carcinoma and concomitant cirrhosis. Waitlist candidacy can be affected by social determinants of health that vary...
5.
Gupta M, Davenport D, Orozco G, Bharadwaj R, Roses R, Evers B, et al.
Surg Oncol
. 2024 Aug;
56:102114.
PMID: 39163797
Introduction: Despite superior outcomes with liver transplantation, cirrhotic patients with HCC may turn to other forms of definitive treatment. To understand perioperative outcomes, we examined perioperative mortality and major morbidity...
6.
Madabhushi V, Wright M, Orozco G, Murphy A, Garcia A, Pope N, et al.
J Rural Health
. 2024 Aug;
41(1):e12871.
PMID: 39160697
Purpose: In rural America, the road to obtaining a liver transplant (LTX) often starts at the primary care provider's (PCP's) office. Patients with end-stage liver disease (ESLD) in rural communities...
7.
Barkovich K, Gibson A, Brahmbhatt S, Tadisetty S, Wilds E, Nelson L, et al.
Abdom Radiol (NY)
. 2024 Jun;
49(12):4521-4530.
PMID: 38900316
With the rising incidence of chronic kidney disease worldwide, an increasing number of patients are expected to require renal transplantation, which remains the definitive treatment of end stage renal disease....
8.
Yang H, Howerton B, Brown L, Izumi T, Cheek D, Brandon J, et al.
Cancers (Basel)
. 2023 Dec;
15(24).
PMID: 38136418
Background: Magnetic resonance imaging (MRI) is a non-invasive imaging modality which, in conjunction with biopsies, provide a qualitative assessment of tumor response to treatment. Intravenous injection of contrast agents such...
9.
Orozco G, Gupta M, Ancheta A, Shah M, Warriner Z, Marti F, et al.
J Trauma Acute Care Surg
. 2023 Nov;
96(5):763-768.
PMID: 37994467
Background: Orthotopic liver transplantation (OLT) is rarely indicated after hepatic trauma but it can be the only therapeutic option in some patients. There are scarce data analyzing the surgical outcomes...
10.
Gedaly R, Orozco G, Ancheta A, Donoho M, Desai S, Chapelin F, et al.
Cells
. 2023 Aug;
12(16).
PMID: 37626877
Background: Regulatory T cell (Treg) therapy is considered an alternative approach to induce tolerance in transplantation. If successful, this therapy may have implications on immunosuppression minimization/withdrawal to reduce drug-induced toxicity...